At the end of next month, it’ll be two years since the Stormont institutions were restored. The reasons for the devolved ...
TORONTO, ON / ACCESS Newswire / January 8, 2026 / Inventus Mining Corp. (TSXV:IVS) ("Inventus" or the "Company")is ...
The Labour Party is sick. Eighteen months after winning a vast majority that should have ensured a full term of parliamentary dominance, Keir Starmer’s government is in the doldrums, with no signal ...
When we hold a neon tube in our hands or see a neon sign we are seeing our cosmic selves illuminated,” Matuszewicz said. “… ...
Impact of AI on productivity is apparent but is still relatively small compared to the considerable investments in the ...
Thirty-plus people gathered on a sunny Friday afternoon to experience Republican Adam Steen, candidate for Iowa governor, at ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...
From the Phantom jet to the helm of Israel’s second-largest university, Prof. Arie Zaban reflects on leadership during war ...
Full conversion of convertible notes reduces long-term liabilities, removes potential equity overhang, and helps ...
Detailed price information for Tempramed Technologies Ltd. (VIVI-CN) from The Globe and Mail including charting and trades.
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback